SheTech-TechBuzz Media Interns Agatha Hunnicutt and Najma Ahmed profile Women Tech Awards finalist Lynn Reichert, exploring how her work at the Utah STEM Action Center expands STEM education, innovation, and food security across Utah communities.
by Agatha Hunnicutt & Najma Ahmed
The Lassonde Entrepreneur Institute awarded over $350,000 in scholarships to 110 students for 2025-26. Recipients gain leadership experience managing programs, workshops, and outreach, building skills while supporting fellow aspiring entrepreneurs.
by Mark Tullis
Angel Studios (Provo, UT) has secured a first-look film partnership with Neal and Ruvé McDonough’s production company, expanding its values-driven content pipeline following multiple successful collaborations.
by Mark Tullis
Angel Studios (Provo, UT) has secured a first-look film partnership with Neal and Ruvé McDonough’s production company, expanding its values-driven content pipeline following multiple successful collaborations.
by Mark Tullis
DiscGenics (Salt Lake City, UT) has treated the first patient in its Phase 3 clinical trial of IDCT, a cell-based therapy targeting lumbar degenerative disc disease, marking a key regulatory and clinical milestone for the company.
by Mark Tullis
SheTech-TechBuzz Media Interns Agatha Hunnicutt and Najma Ahmed profile Women Tech Awards finalist Lynn Reichert, exploring how her work at the Utah STEM Action Center expands STEM education, innovation, and food security across Utah communities.
by Agatha Hunnicutt & Najma Ahmed
Nucleus Fund invests in Provo's Terraphene, a hemp-based materials startup with a nine-figure pallet supply deal, fire- and strength-tested building materials, and a pitch to help refill the Great Salt Lake by replacing thirsty alfalfa acreage with hemp.
DHS named Fortem Technologies (Lindon, UT) the only small business among seven prime contractors on a five-year, $1B+ counter-drone IDIQ. CEO Jon Gruen discusses the win, subcontractors Lockheed Martin and Microsoft, and plans to scale Utah manufacturing.
South Jordan-based Obra emerges from stealth with two linked products, Obra Jobs and Obra Hire, betting that AI broke hiring's inbound signal and that a trust-first, outbound-focused platform can restore it.
SheTech-TechBuzz Media Interns Agatha Hunnicutt and Najma Ahmed profile Women Tech Awards finalist Lynn Reichert, exploring how her work at the Utah STEM Action Center expands STEM education, innovation, and food security across Utah communities.
by Agatha Hunnicutt & Najma Ahmed
Fortem Technologies’ DroneHunter interceptor was selected by the Pentagon's JIATF-401 program as the first procurement under Replicator 2, validating the system’s readiness for rapid counter-drone deployment.
by Mark Tullis
Fortem Technologies’ DroneHunter interceptor was selected by the Pentagon's JIATF-401 program as the first procurement under Replicator 2, validating the system’s readiness for rapid counter-drone deployment.
by Mark Tullis
The Lassonde Entrepreneur Institute awarded over $350,000 in scholarships to 110 students for 2025-26. Recipients gain leadership experience managing programs, workshops, and outreach, building skills while supporting fellow aspiring entrepreneurs.
by Mark Tullis
The Lassonde Entrepreneur Institute awarded over $350,000 in scholarships to 110 students for 2025-26. Recipients gain leadership experience managing programs, workshops, and outreach, building skills while supporting fellow aspiring entrepreneurs.
by Mark Tullis
Angel Studios (Provo, UT) has secured a first-look film partnership with Neal and Ruvé McDonough’s production company, expanding its values-driven content pipeline following multiple successful collaborations.
by Mark Tullis
Angel Studios (Provo, UT) has secured a first-look film partnership with Neal and Ruvé McDonough’s production company, expanding its values-driven content pipeline following multiple successful collaborations.
by Mark Tullis
DiscGenics (Salt Lake City, UT) has treated the first patient in its Phase 3 clinical trial of IDCT, a cell-based therapy targeting lumbar degenerative disc disease, marking a key regulatory and clinical milestone for the company.
by Mark Tullis